Researcher

Julian L. Goggi is a Principal Investigator at the Institute of Bioengineering and Bioimaging (IBB). Goggi leads the Isotopic Molecular Imaging Laboratory (IMIL), a state-of-the-art nuclear imaging facility focussing on the development of novel radiopharmaceuticals for diagnosis and treatment stratification across multiple disease areas, including immuno-oncology, oncology, neurology, and metabolic disease.

Goggi received his PhD from Imperial College London in 2002 before working in industry for MSD and GE Healthcare prior to joining A*STAR in 2010. Currently, Goggi is the Imaging Theme lead in the pan-Singapore IAF-PP grant for Cancer ImmunoTherapy Imaging (CITI), developing novel nuclear imaging biomarkers to stratify cancer immunotherapy therapeutic interventions and holds an adjunct appointment in the Department of Physiology, Yong Loo Lin School of Medicine at the National University of Singapore. Goggi has published over 50 research papers and holds numerous patents in the field of imaging diagnostics and development.